Cynomolgus / Rhesus macaque CD19 (20-292) Protein, Fc Tag
Proteins and Peptides
- 貨號 Cat. No.
- CD9-C5251
- 規格 Size
- 100ug
- 品牌 Brand
- ACROBiosystems
- Species
- Cynomolgus / Rhesus macaque
- Conjugate
- Unconjugated
- Expression System
- HEK293
- Tag
- Fc Tag
Description
Source :
Cynomolgus / Rhesus macaque CD19 (20-292), Fc Tag (CD9-C5251) is expressed from human 293 cells (HEK293). It contains AA Pro 20 - Lys 292 (Accession # F7F486). In the region Pro 20 - Lys 292, the AA sequence of Cynomolgus and Rhesus macaque CD19 are homologus.
Molecule : CD19
Synonyms : CD19,B4,CVID3,MGC12802
Format : Powder
Category : Bio-Markers & CD Antigens
Accession : N/A
Storage : -20℃
Shipping condition : Powder,RT
Molecular Weight : 56.7kDa
Characteristics :
This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 56.7kDa. The protein migrates as 62-95 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level : Less than 1.0 EU per μg by the LAL method.
Buffer : Tris with Glycine, Arginine and NaCl, pH7.5
Description :
B-lymphocyte antigen CD19 (CD19) is also known as B-lymphocyte surface antigen B4, Differentiation antigen CD19 and T-cell surface antigen Leu-12, which is a single-pass type I membrane protein and contains two Ig-like C2-type (immunoglobulin-like) domains. CD19 forms a complex with CD21, CD81 and CD225 in the membrane of mature B cells. CD19 interacts with GRB2 and SOS when phosphorylated on Tyr-348 and/or Tyr-378. CD19 also interacts with PLCG2 when phosphorylated on Tyr-409. CD19 is an important pan B cell marker and co-stimulatory protein in humans and mice. CD19 is a hallmark differentiation antigen of the B cell lineage and positively regulates antigen receptor signal transduction in mature B cells. CD19 defines signaling thresholds for the Ag receptor as well as other cell surface receptors that regulate B lymphocyte selection, activation, and differentiation. Defects in CD19 are a cause of hypogammaglobulinemia.
References :
(1) Kozmik Z., et al., 1992, Mol. Cell. Biol. 12:2662-2672. (2) Kuroki K., et al., 2002, Genes Immun. 3:S21-S30. (3) Stamenkovic I., 1998, Seed B.J. Exp. Med. 168:1205-1210.

